Trial Profile
Establish the suitable strategy of maintenance therapy for rheumatoid arthritis patient with methotrexate and adalimumab
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms MASTER
- 01 Dec 2015 New trial record